This inventor holds 4 USPTO granted patents. Top assignee: Chisso Corporation. Active years: 1991-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Minamata, JP (1991)
- Kanagawaken, JP (1997)
- Kanagawa, JP (2003 - 2007)
Company Filing History:
Years Active: 1991-2007
Title: Yasuo Urata: Innovator in Pharmaceutical Chemistry
Introduction
Yasuo Urata is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of optically active compounds. With a total of 4 patents to his name, Urata's work has had a substantial impact on the creation of important pharmaceutical intermediates.
Latest Patents
Urata's latest patents include innovative processes for producing optically active nitro alcohol derivatives and optically active amino alcohol derivatives. These compounds are crucial for synthesizing pharmaceuticals such as (R)-albutamin and (R)-sarmeterol, which are effective bronchodilators. His patents detail the processes for producing 1-substituted phenyl-2-nitro alcohol derivatives and 1-substituted phenyl-2-amino alcohol derivatives, showcasing his expertise in this specialized area of chemistry.
Career Highlights
Throughout his career, Yasuo Urata has been associated with Chisso Corporation, where he has been able to apply his innovative ideas in a practical setting. His work has not only advanced the field of pharmaceutical chemistry but has also contributed to the development of new therapeutic agents that can improve patient outcomes.
Collaborations
Urata has collaborated with notable colleagues such as Mamoru Fujita and Masakatsu Shibasaki. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the research process.
Conclusion
Yasuo Urata's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the development of essential pharmaceutical compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
